We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunofluorescent Imaging/Analysis Solution Quantifies Protein Biomarkers

By LabMedica International staff writers
Posted on 30 Nov 2011
An immunofluorescent imaging and analysis solution provides an improvement on traditional immunohistochemistry.

The new product enables users to leverage the combined imaging and analysis power of Vectra 2 and AQUA technology, an image analysis system, to provide an integrated solution to advance the identification and validation of new drug targets and improve assessment of drug response.

Vectra 2 is an automated multiplexed and multispectral tissue-imaging platform. More...
AQUA technology is capable of precisely measuring protein biomarker concentration with sub-cellular resolution in tissue sections, enabling fully objective, reproducible, and automated analysis to guide drug development and therapeutic decision-making.

Caliper Life Sciences (Hopkinton, MA, USA) and HistoRx (Branford, CT, USA) collaborated on the new immunofluorescent imaging and analysis solution that will deliver objective, quantitative, and reproducible immunohistochemistry results. Caliper will distribute the integrated product in the scientific market; the two companies are also exploring collaborations in diagnostics and clinical research.

AQUAServe is new server-based queuing software designed to enable “walk-away” operation for multiple specimens while retaining the full functionality of HistoRx's flagship AQUAnalysis software.

Caliper Life Sciences, a Perkin-Elmer Company, launched the new Vectra 2 with AQUA technology, an integrated solution for quantification of protein biomarkers in tissue, at the Molecular Targets & Cancer Therapeutics meeting held from November 12-16, 2011, in San Francisco (CA, USA)

"The Vectra 2 with AQUA technology represents a significant move forward for those interested in digital pathology with both brightfield and fluorescent capabilities," said Mark Gustavson, PhD, director of operations at HistoRx.

Related Links:
Caliper Life Sciences
HistoRx


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Immunofluorescence Analyzer
IFA System
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.